Human Embryonic Stem Cell-Derived Oligodendrocytes: Protocols and Perspectives
Open accessThe DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
Abstract
Oligodendrocytes play a fundamental supportive role in the mammalian central nervous system (CNS) as the myelinating-glial cells. Disruption of fast axonal transport mechanisms can occur as a consequence of mature oligodendrocyte loss following spinal cord injury, stroke, or due to neuroinflammatory conditions, such as multiple sclerosis. As a result of the limited remyelination ability in the CNS after injury or disease, human embryonic stem cells (hESCs) may prove to be a promising option for the generation and replacement of mature oligodendrocytes. Moreover, hESC-derived oligodendrocytes may be experimentally utilized to unravel fundamental questions of oligodendrocyte development, along with their therapeutic potential through growth factor support of axons and neurons. However, an intensive characterization and examination of hESC-derived oligodendrocytes prior to preclinical or clinical trials is required to facilitate greater success in their integration following cellular replacement therapy (CRT). Currently, the protocols utilized to derive oligodendrocytes from hESCs consist of significant variations in culture style, time-length of differentiation, and the provision of growth factors in culture. Further, these differing protocols also report disparate patterns in the expression of oligodendroglial markers by these derived oligodendrocytes, throughout their differentiation in culture. We have comprehensively reviewed the published protocols describing the derivation of oligodendrocytes from hESCs and the studies that examine their efficacy to remyelinate, along with the fundamental issues of their safety as a viable CRT. Additionally, this review will highlight particular issues of concern and suggestions for troubleshooting to provide investigators critical information for the future improvement of establishing in vitro hESC-derived oligodendrocytes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Kessaris, N., Fogarty, M., Iannarelli, P., Grist, M., Wegner, M., & Richardson, W. D. (2006) · Nature Neuroscience · doi:10.1038/nn1620 · Cited by 1,195 · cited 4×
“The generation of oligodendrocytes from hESC cultures over different time frames may be a result of the complex nature of gliogenesis and the heterogeneity of oligodendrocytes generated [33,35,36,48].”
InfluentialTNFα promotes proliferation of oligodendrocyte progenitors and remyelination
Arnett, H. A., Mason, J., Marino, M., Suzuki, K., Matsushima, G. K., & Ting, J. P.-Y. (2001) · Nature Neuroscience · doi:10.1038/nn738 · Cited by 1,012
PDGFRA/NG2 glia generate myelinating oligodendrocytes and piriform projection neurons in adult mice
Rivers, L. E., Young, K. M., Rizzi, M., Jamen, F., Psachoulia, K., Wade, A., Kessaris, N., & Richardson, W. D. (2008) · Nature Neuroscience · doi:10.1038/nn.2220 · Cited by 961
Retinoic acid in the development, regeneration and maintenance of the nervous system
Maden, M. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2212 · Cited by 896 · cited 1×
“RA may also be important for the organization of the ventral and dorsal axis of the neural tube, and the anterior spinal cord and posterior hindbrain during development [56].”
Kirkeby, A., Grealish, S., Wolf, D. A., Nelander, J., Wood, J., Lundblad, M., Lindvall, O., & Parmar, M. (2012) · Cell Reports · doi:10.1016/j.celrep.2012.04.009 · Cited by 662 · cited 1×
“The potential of hPSCs has been shown with the deployment of differentiated neural precursors with tantalizing results in animal models of spinal cord injury (SCI) [1-3], Huntington’s disease [4-6] and Parkinson’s disease [7, 8].”
Wang, S., Bates, J., Li, X., Schanz, S., Chandler-Militello, D., Levine, C., Maherali, N., Studer, L., Hochedlinger, K., Windrem, M., et al. (2013) · Cell Stem Cell · doi:10.1016/j.stem.2012.12.002 · Cited by 586 · cited 7×
“The derived OPCs displayed a greater myelination potential than OPCs isolated from human fetal brain tissue in vitro and in vivo [97].”
InfluentialCarson, M. J., Behringer, R. R., Brinster, R. L., & McMorris, F. A. (1993) · Neuron · doi:10.1016/0896-6273(93)90173-o · Cited by 474
bHLH Transcription Factor Olig1 Is Required to Repair Demyelinated Lesions in the CNS
Arnett, H. A., Fancy, S. P. J., Alberta, J. A., Zhao, C., Plant, S. R., Kaing, S., Raine, C. S., Rowitch, D. H., Franklin, R. J. M., & Stiles, C. D. (2004) · Science · doi:10.1126/science.1103709 · Cited by 416
Miyoshi, G., Butt, S. J. B., Takebayashi, H., & Fishell, G. (2007) · The Journal of Neuroscience · doi:10.1523/jneurosci.1807-07.2007 · Cited by 400 · cited 1×
“For example, OLIG2-expressing NPs were shown to differentiate into motor neurons and oligodendrocytes in the ventral spinal cord as well as into interneurons and oligodendrocytes in the forebrain [45-47].”
Richardson, W. D., Kessaris, N., & Pringle, N. (2006) · Nature reviews. Neuroscience · doi:10.1038/nrn1826 · Cited by 385 · cited 17×
“It is documented that EGF is crucial for early neural patterning in several regions of the developing CNS [51,52].”
InfluentialSpinal cord injury is accompanied by chronic progressive demyelination
Totoiu, M. O., & Keirstead, H. S. (2005) · Journal of Comparative Neurology · doi:10.1002/cne.20517 · Cited by 372
Petryniak, M. A., Potter, G. B., Rowitch, D. H., & Rubenstein, J. L. R. (2007) · Neuron · doi:10.1016/j.neuron.2007.06.036 · Cited by 371 · cited 2×
“2 [40,54,55].”
Axin2 as regulatory and therapeutic target in newborn brain injury and remyelination
Fancy, S. P. J., Harrington, E. P., Yuen, T. J., Silbereis, J. C., Zhao, C., Baranzini, S. E., Bruce, C. C., Otero, J. J., Huang, E. J., Nusse, R., et al. (2011) · Nature Neuroscience · doi:10.1038/nn.2855 · Cited by 349 · cited 1×
“This may well be a common issue in other models and human diseases such as multiple sclerosis (MS), where the aggressive neuroinflammation limits the survival and differentiation of transplanted OPCs [114,115].”
Flandin, P., Kimura, S., & Rubenstein, J. L. R. (2010) · The Journal of Neuroscience · doi:10.1523/jneurosci.4228-09.2010 · Cited by 176
Hu, B.-Y., Du, Z.-W., Li, X.-J., Ayala, M., & Zhang, S.-C. (2009) · Development · doi:10.1242/dev.029447 · Cited by 169 · cited 7×
“Although Sundberg et al., and Hu et al., have described the most protracted protocol (ie, 3 months), the benefits of using such protocols are that they resemble the time required for the early appearance of OPCs in human embryos, which arrive at the end of the first trimester [24,27,28,49].”
InfluentialMicroRNA Expression Profiling of Oligodendrocyte Differentiation from Human Embryonic Stem Cells
Letzen, B. S., Liu, C., Thakor, N. V., Gearhart, J. D., All, A. H., & Kerr, C. L. (2010) · PLoS ONE · doi:10.1371/journal.pone.0010480 · Cited by 119
CNS Myelin Paranodes Require Nkx6-2 Homeoprotein Transcriptional Activity for Normal Structure
Southwood, C., He, C., Garbern, J., Kamholz, J., Arroyo, E., & Gow, A. (2004) · The Journal of Neuroscience · doi:10.1523/jneurosci.3479-04.2004 · Cited by 94 · cited 1×
“2, in particular, is an important transcription factor for normal myelination asitbindstothepromoterregion ofmyelin binding protein ( mbP ) [72].”
Li, Y., Gautam, A., Yang, J., Qiu, L., Melkoumian, Z., Weber, J., Telukuntla, L., Srivastava, R., Whiteley, E. M., & Brandenberger, R. (2013) · Stem Cells and Development · doi:10.1089/scd.2012.0508 · Cited by 47
Cited by
Douvaras, P., Wang, J., Zimmer, M., Hanchuk, S., O’Bara, M. A., Sadiq, S., Sim, F. J., Goldman, J., & Fossati, V. (2014) · Stem Cell Reports · doi:10.1016/j.stemcr.2014.06.012 · Cited by 302
“Since most protocols for oligodendrocyte differentiation have been optimized using only one or two hESC lines and their reproducibility with iPSC lines is controversial (Alsanie et al., 2013), we tested our protocol with two hESC and four hiPSC lines derived from PPMS patients.”
MethodStem cell derived oligodendrocytes to study myelin diseases
Chanoumidou, K., Mozafari, S., Baron‐Van Evercooren, A., & Kuhlmann, T. (2020) · Glia · doi:10.1002/glia.23733 · Cited by 62
“Numerous strategies have been developed for the differentiation of human ESC to OPC (reviewed in [Alsanie et al., 2013]).”
MethodMarangon, D., Caporale, N., Boccazzi, M., Abbracchio, M. P., Testa, G., & Lecca, D. (2021) · Frontiers in Cellular Neuroscience · doi:10.3389/fncel.2021.748849 · Cited by 34
“…Oligo6 cells, which are extremely enriched in Opalin, and Oligo1, were found significantly reduced in MS, both in normal-appearing white matter and lesions, adding evidence to the concept that normalappearing white matter is indeed not “normal” (de Groot et al., 2013; Angelini et al., 2021).”
BackgroundWhite Matter in Crisis: Oligodendrocytes and the Pathophysiology of Multiple Sclerosis
García-Domínguez, M. (2025) · Cells · doi:10.3390/cells14181408 · Cited by 13
Metadata
- Authors
- Alsanie, W. F., Niclis, J. C., & Petratos, S.
- Venue
- Stem Cells and Development
- Publisher
- SAGE Publications
- Published
- 2013-04-28
- Volume
- 22
- Issue
- 18
- Pages
- 2459-2476
- ISSN
- 1525-8165 (ISSN-L)
- 1547-3287
- 1557-8534
- OpenAlex
- W2045923526
- Cited by
- 51
- References
- 18
- FWCI
- 2.00
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.